These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34357564)

  • 1. Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.
    Ochoa ELM
    Cell Mol Neurobiol; 2022 Jan; 42(1):85-97. PubMed ID: 34357564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
    Won E; Kim YK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
    Damri O; Shemesh N; Agam G
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
    Mishra HK; Mandyam AD; Trenet W; Wei H; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Gershon E; McInnis MG; ; Kelsoe JR; McCarthy MJ
    Neuropharmacology; 2023 Mar; 226():109410. PubMed ID: 36608815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
    Atack JR; Broughton HB; Pollack SJ
    Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.
    Hajek T; Bauer M; Simhandl C; Rybakowski J; O'Donovan C; Pfennig A; König B; Suwalska A; Yucel K; Uher R; Young LT; MacQueen G; Alda M
    Psychol Med; 2014 Feb; 44(3):507-17. PubMed ID: 23721695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis.
    Hajek T; Kopecek M; Höschl C; Alda M
    J Psychiatry Neurosci; 2012 Sep; 37(5):333-43. PubMed ID: 22498078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder.
    Mishra HK; Wei H; Rohr KE; Ko I; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Berrettini WH; Brennand KJ; Calabrese JR; Coryell WH; Frye M; Gage F; Gershon E; McInnis MG; Nurnberger J; Oedegaard KJ; Zandi PP; Kelsoe JR; McCarthy MJ
    Eur Neuropsychopharmacol; 2023 Sep; 74():1-14. PubMed ID: 37126998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders.
    Puglisi-Allegra S; Ruggieri S; Fornai F
    Transl Psychiatry; 2021 Jul; 11(1):366. PubMed ID: 34226487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics in the treatment of bipolar disorder.
    Singh J; Chen G; Canuso CM
    Handb Exp Pharmacol; 2012; (212):187-212. PubMed ID: 23129333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
    Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
    Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wnt signaling pathway in bipolar disorder.
    Gould TD; Manji HK
    Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is lithium effective in alleviating bipolar disorder?
    Sato K
    Med Hypotheses; 2021 Feb; 147():110484. PubMed ID: 33444905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord.
    Calderó J; Brunet N; Tarabal O; Piedrafita L; Hereu M; Ayala V; Esquerda JE
    Neuroscience; 2010 Feb; 165(4):1353-69. PubMed ID: 19932742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.